Eprizet 20 mg/10 mg tablete
| Name | Eprizet 20 mg/10 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-797006261 |
| Active Substance | rosuvastatinkalcij ezetimib |
| Composition | jedna tableta sadrži 20 mg rosuvastatina (u obliku rosuvastatinkalcija) i 10 mg ezetimiba |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-797006261-01] 30 tableta u blisteru, u kutiji [HR-H-797006261-02] 84 tablete u blisteru, u kutiji [HR-H-797006261-03] 90 tableta u blisteru, u kutiji [HR-H-797006261-04] 10 tableta u blisteru, u kutiji [HR-H-797006261-05] 98 tableta u blisteru, u kutiji [HR-H-797006261-06] 100 tableta u blisteru, u kutiji [HR-H-797006261-07] |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 13.02.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/69 |
| Registration Number | 381-12-01/70-24-06 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C10BA06 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
